ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) Depreciation & Amortization (CF) (2010 - 2026)

Updated

ProPhase Labs (PRPH) posted Depreciation & Amortization (CF) of $963,000 for Q2 2026, down 28.6% from $1.35 million a year earlier but up 0.1% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at ProPhase Labs was $3.93 million, down 33.2% year-over-year; for FY2025, it was $4.83 million, down 21.9% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 60.8% (FY2020 to FY2025).
  • In prior years, ProPhase Labs' Depreciation & Amortization (CF) was $6.19 million in FY2024 (+2.3%), $6.05 million in FY2023 (+28.2%), $4.72 million in FY2022 (+45.9%) and $3.23 million in FY2021 (+620.3%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $926,000 in Q3 2021 to a high of $1.8 million in Q3 2023 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last eight quarters, with an average decline of 21.6% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2021, with growth of 976.7%; the weakest was Q4 2025, with a decline of 36.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $962,000 (Q1 2026), $963,000 (Q4 2025) and $1.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 2.12 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 194.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 1.93 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 1.62 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00 963,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 963,000.00
Mar 31, 2026 962,000.00
Dec 31, 2025 963,000.00
Sep 30, 2025 1.04 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 1.52 Mn
Sep 30, 2024 1.52 Mn
Jun 30, 2024 1.54 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 1.62 Mn
Sep 30, 2023 1.80 Mn
Jun 30, 2023 1.35 Mn
Mar 31, 2023 1.29 Mn
Dec 31, 2022 926,000.00
Sep 30, 2022 1.28 Mn
Jun 30, 2022 1.27 Mn
Mar 31, 2022 1.25 Mn
Dec 31, 2021 1.19 Mn
Sep 30, 2021 926,000.00
API Access

ProPhase Labs Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRPH&period=max&api_key=YOUR_API_KEY